University of Michigan School of Nursing
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT03625492
This study evaluates whether eliminating certain ingredients (caffeine, alcohol, artificial sweeteners, acidic juices) consumed in beverages reduces bladder symptoms of urinary frequency and urgency. Women with overactive bladder will be recruited. Half of these women will receive instructions to replace beverages containing these ingredients with beverages such as water or milk. The other half of participants will receive instructions on following the United States Department of Agriculture guidelines on healthy eating.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
It is commonly believed that it is better for women's bladders if intake of certain beverages is eliminated. Advice is given to women with frequency/urgency symptoms to avoid coffee or tea, sodas or pop, or any other drinks that contain alcohol, caffeine, artificial sweeteners or high acidic content. Although the investigators do not know the direct cause and effect of consuming beverages with these ingredients, there might be reduction in "irritating" sensation to toilet often because of urgency if the beverages with these ingredients are replaced by "non-irritating" beverages.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group will receive a 7 minute video teaching participants to replace beverages that include caffeine, alcohol, artificial sweeteners, or acidic juices with equal volume intake of water, milk, or other beverages that do not have these ingredients in them.
This group will receive a 7 minute video teaching them the USDA guidelines for healthy eating.
Time frame: 2-weeks
Average number of times urinated per day on 3-day bladder diary
Time frame: 2-weeks
Average volume of urine per day with each toileting event on 3-day bladder diary
Time frame: 2-weeks
The adapted question reads, "Typically, when you needed to go to the bathroom today you could…" with the five potential responses ranging from "make the urge go away" to "already feel the urine coming out." Urgency will be measured as the mean reported score for each three-day time period for the perception of bladder fullness questionnaires.
Time frame: 2-weeks
On 3-day diary, participants will be asked to indicate their perception of bladder fullness when they urinated that day: "no bladder sensation," "urinating could easily be delayed for more than 30-60 minutes," "urinating could only be delayed for 30 minutes," "urinating could only be delayed for 5 minutes" and "immediate urinating will be mandatory and/or fear of leakage."
Time frame: 2-months
The investigators will use only the "bother" questions of this larger Questionnaire about bladder symptoms. We modified the original think-back period of 4-weeks to instead think back to "the past 3 days" to characterize the bother of bladder symptoms under the varying conditions of each specific intervention period. Bother will be measured on the final day on the bottom of each of the 3-day diaries.
Time frame: 2-months
Average number of times urinated per day on 3-day bladder diary
University of Michigan
Other
Effect of Potentially Irritating Beverages on Overactive Bladder Symptoms
Acronym: FABULUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04599283
BPH, BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms
Virginia Beach, Virginia, United States
View Trial DetailsNCT05308979
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Orange, California, United States
View Trial DetailsNCT06508944
Bladder, Overactive, Female Genitourinary Disease
Ratchathewi, Bangkok, Thailand
View Trial DetailsNCT04547920
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Stanford, California, United States
View Trial Details